Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression
- PMID: 28257825
- DOI: 10.1016/j.bbi.2017.02.020
Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression
Abstract
Introduction: Population-based studies have associated inflammation, particularly higher C-reactive protein (CRP), with depressive severity, but clinical trials in major depressive disorder were rather non-specific without examining the role of gender. We aimed to investigate the association between CRP and overall depression severity including specific depressive symptoms and to examine potential gender differences.
Methods: We included 231 individuals with major depressive disorder from the Genome-Based Therapeutics Drugs for Depression (GENDEP) study. At baseline, we assessed high-sensitivity CRP levels and psychopathology with the Montgomery Aasberg Depression Rating Scale (MADRS). We performed linear regression analyses to investigate the association between baseline CRP levels with overall MADRS severity and specific symptoms at baseline and adjusted for age, gender, anti-inflammatory and psychotropic drug treatment, body mass index, smoking, inflammatory diseases, and recruitment center.
Results: Higher CRP levels were significantly associated with greater overall MADRS symptom severity (p=0.02), which was significant among women (p=0.02) but not among men (p=0.68). Among women, higher CRP was associated with increased severity on observed mood, cognitive symptoms, interest-activity, and suicidality, but we found no significant associations among men. Interaction analyses showed no significant gender differences on the overall MADRS score or specific symptoms.
Discussion: Our results support the sickness syndrome theory suggesting that chronic low-grade inflammation may be associated with a subtype of depression. The potential gender differences in psychopathology may be explained by biological and/or psychosocial factors, e.g. differential modulation of immune responses by sex hormones. Clinical studies should investigate symptom-specific and/or gender-specific treatment guided by peripheral inflammatory markers.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.Am J Psychiatry. 2014 Dec 1;171(12):1278-86. doi: 10.1176/appi.ajp.2014.14010094. Epub 2014 Oct 31. Am J Psychiatry. 2014. PMID: 25017001 Clinical Trial.
-
Clinically relevant and simple immune system measure is related to symptom burden in bipolar disorder.Acta Neuropsychiatr. 2018 Oct;30(5):297-305. doi: 10.1017/neu.2017.34. Epub 2017 Dec 7. Acta Neuropsychiatr. 2018. PMID: 29212563
-
White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder.Aust N Z J Psychiatry. 2017 Apr;51(4):355-365. doi: 10.1177/0004867416644508. Epub 2016 Jul 11. Aust N Z J Psychiatry. 2017. PMID: 27126391 Clinical Trial.
-
C-Reactive Protein as a Biomarker for Major Depressive Disorder?Int J Mol Sci. 2022 Jan 30;23(3):1616. doi: 10.3390/ijms23031616. Int J Mol Sci. 2022. PMID: 35163538 Free PMC article. Review.
-
Depression and peripheral inflammatory profile of patients with obesity.Psychoneuroendocrinology. 2018 May;91:132-141. doi: 10.1016/j.psyneuen.2018.03.005. Epub 2018 Mar 9. Psychoneuroendocrinology. 2018. PMID: 29550676 Review.
Cited by
-
Biomarkers in the Diagnosis and Prediction of Medication Response in Depression and the Role of Nutraceuticals.Int J Mol Sci. 2024 Jul 22;25(14):7992. doi: 10.3390/ijms25147992. Int J Mol Sci. 2024. PMID: 39063234 Free PMC article. Review.
-
Increased C-Reactive Protein in Patients with Post-Stroke Depression: A Meta-analysis of Cohort Study.Alpha Psychiatry. 2024 Mar 1;25(2):124-131. doi: 10.5152/alphapsychiatry.2024.231338. eCollection 2024 Mar. Alpha Psychiatry. 2024. PMID: 38798800 Free PMC article. Review.
-
C-reactive protein concentrations diverge as a function of substance use disorder: A pre-registered replication in a clinical sample.Drug Alcohol Depend. 2024 Jul 1;260:111323. doi: 10.1016/j.drugalcdep.2024.111323. Epub 2024 May 8. Drug Alcohol Depend. 2024. PMID: 38733735
-
The association between depressive symptoms and high-sensitivity C-reactive protein: Is body mass index a moderator?Brain Behav Immun Health. 2024 Apr 18;38:100773. doi: 10.1016/j.bbih.2024.100773. eCollection 2024 Jul. Brain Behav Immun Health. 2024. PMID: 38698915 Free PMC article.
-
B cells and the stressed brain: emerging evidence of neuroimmune interactions in the context of psychosocial stress and major depression.Front Cell Neurosci. 2024 Apr 8;18:1360242. doi: 10.3389/fncel.2024.1360242. eCollection 2024. Front Cell Neurosci. 2024. PMID: 38650657 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous